A novel regimen of doravirine and islatravir was noninferior to a common HIV therapy as an initial HIV treatment, according ...

Vaishali Gauba returned to India after five years in the US because she didn't get a visa. Differences between life in the US and India made her feel what's known as reverse culture shock. Gauba ...

Singapore's TFR hit a record low of 0.87 in 2025, sparking urgency to reverse the trend, with DPM Gan Kim Yong warning of severe demographic consequences. High costs, workplace pressures, and shifting ...

Researchers discovered how anti-cancer drugs called HDAC inhibitors help treat pancreatic cancer by altering scar tissue (fibroblast) development. The findings suggest HDAC inhibitors could be ...

Q2 top-line data: Avalo expects to report top-line results in the second quarter from the completed Phase 2b LOTUS trial of AVTX-009, which enrolled over 250 hidradenitis suppurativa (HS) patients and ...

Enanta is advancing two RSV molecules, zelicapavir and EDP-323, with a Phase 3 trial planned for zelicapavir. The company’s I&I portfolio includes three programs targeting KIT, STAT6, and MRGPRX2.